COST EFFECTIVENESS OF TREATING IVIG-RESISTANT KAWASAKI DISEASE CHILDREN WITH SECOND ROUND IVIG VERSUS INFLIXIMAB

Johnson, J; Brinton, D; Simpson, K; Burns, J; Simpson, A

VALUE IN HEALTH, 2023; 26 (6): S70